Presentation is loading. Please wait.

Presentation is loading. Please wait.

Sarah Leary, MD MS CBTTC 5/25/2016

Similar presentations


Presentation on theme: "Sarah Leary, MD MS CBTTC 5/25/2016"— Presentation transcript:

1 Sarah Leary, MD MS CBTTC 5/25/2016
A CBTTC Project: Genomic Evaluation of Malignant Pediatric Cortical Tumors Sarah Leary, MD MS CBTTC 5/25/2016

2 Mountain climbing is a good metaphor for cancer research -Peter Phillips (paraphrasing)

3 What do cancer biology and cancer medicine have in common?
COMPUTER SCIENCE AND BIOINFORMATICS BIOLOGY Oncogenes Tumor suppressors Gene expression Whole genome analysis Epigenetic changes MEDICINE Surgery Radiation Chemotherapy High dose therapy Survival Scientific method Aim to cure cancer $$$$?

4 Malignant brain tumor in a child

5 Survival is poor for children diagnosed with sPNET
50% survival on toxic treatment which cures 85% of medulloblasoma No medical progress in the past 20 years No current international strategy

6 Molecular approach to CNS-PNET
Li Cancer Cell 2009 Picard Lancet 2012

7 Classification of glioblastoma by DNA methylation

8 Classification of CNS PNET by DNA methylation

9 Extent of resection is the best predictor of survival in children with brain tumors

10 Pilot study of sequencing panel in malignant pediatric supratentorial tumors
Original Original

11 Pilot study of sequencing panel in malignant pediatric supratentorial tumors

12 Patient 3 MSH2

13 Pilot study of sequencing panel in malignant pediatric supratentorial tumors
Original Original

14 Evaluation of potential therapeutics in a laboratory model of CNS PNET model
Original Original

15 CBTTC Project: Malignant Cortical Tumors
RATIONALE Clinical need Children without standard of care or study options 50% survival Potential for rapid impact Molecular subtyping promising Lack of connection with clinically relevant factors

16 CBTTC Project: Malignant Cortical Tumors
AIMS Unbiased approach to molecularly characterize malignant pediatric supratentorial tumors Evaluate relationship between molecular subgroup, treatment and survival Craniospinal versus focal radiation Combination chemotherapy New agents

17 CBTTC Project: Malignant Cortical Tumors
Biology in the context of the patient Risk Stratification Therapy selection International consensus and collaboration MEDICINE >70 children Treatment Survival BIOLOGY RNA seq Methylation Sequencing DATA SHARING – In 2 weeks 6/12/2016 at pre-ISPNO PNET group!!!

18 What can the CBTTC do for children with brain tumors?
Molecular diagnosis, Targeted therapy, Precision medicine MEDICINE INFORMATICS BIOLOGY

19 Thanks and Questions? Funding: Children’s Brain Tumor Foundation
Co-Investigators: Pathology: Bonnie Cole Seattle site CRA: Jeff Stevens CHOP/CBTTC: Angela Waanders, Adam Resnick CBTTC founding sites: CHOP, Lurie Children’s, Pittsburgh


Download ppt "Sarah Leary, MD MS CBTTC 5/25/2016"

Similar presentations


Ads by Google